UCI NOTES: Coach Russell Turner gets emotional talking about Anteaters’ NIT journey
UCI coach Russell Turner with Devin Tillis (left) and Jurian Dixon following Wednesday’s game. (PHOTO: Tim Burt, OC Sports Zone). UC Irvine men’s basketball coach Russell Turner got emotional Wednesday night talking about what the Anteaters 81-77 overtime victory over University of Alabama-Birmingham in the quarterfinal round of the NIT Read More
Marwynn Valued at $71M After $8M IPO
A new small company that combines distribution of Asian foods with indoor home products made its public debut this month. Irvine-based Marwynn Holdings Inc. opened on the Nasdaq on March 13 at $4 per share under the ticker “MWYN,” raising $8 million in gross proceeds. Marwynn in January had anticipated Read More
Beta Bionics Explodes to $65.1M in Revenue
One of Orange County’s fastest-growing public companies only went public two months ago. Beta Bionics Inc.’s concept of an artificial pancreas that regulates blood sugar levels in people with type 1 diabetes (T1D) was well received by Wall Street. It raised an upsized $234.6 million during its January debut, $120 Read More
Fastest-Growing Public Cos. Ride Healthcare Boom
The county’s fastest-growing publicly traded companies grew revenue by an average of 58% during a two-year span ending Dec. 31, 2024. Nineteen of Orange County’s 50 biggest publicly traded companies made the list, with a cutoff at a minimum 15% or more growth. The lists are broken into three categories: Read More
Rapid Rise: Rivian Doubles Revenue
Rivian Automotive Inc., which has faced a lot of investor criticism about whether it can survive, has proven one thing for certain—its vehicles are popular. The Irvine-based maker of electric vehicles more than doubled its annual revenue over the past two years to $5 billion, up from $1.7 billion in Read More
Tarsus Raises $134.8M Public Offering
Tarsus Pharmaceuticals Inc. closed an upsized $134.8 million public offering this month. The Irvine-based biopharmaceutical company plans to use net proceeds to boost commercialization of its eyedrop Xdemvy in the U.S., as well as develop treatments for other diseases such as ocular rosacea and Lyme disease, according to a Feb. Read More
Aeon Biopharma CEO to Step Down Next Week
Aeon Biopharma Inc. has announced that Marc Forth is stepping down as chief executive and president, effective April 4. The Irvine-based biopharmaceutical company appointed Jost Fischer, current chairman of the board, as interim CEO. “On behalf of the Board, I want to thank Marc for his invaluable contributions to AEON Read More